1. Home
  2. MMU vs EOLS Comparison

MMU vs EOLS Comparison

Compare MMU & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Managed Municipals Fund Inc.

MMU

Western Asset Managed Municipals Fund Inc.

HOLD

Current Price

$10.09

Market Cap

561.5M

Sector

Finance

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$6.18

Market Cap

454.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MMU
EOLS
Founded
1992
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
561.5M
454.4M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
MMU
EOLS
Price
$10.09
$6.18
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$15.50
AVG Volume (30 Days)
128.8K
718.6K
Earning Date
01-01-0001
05-04-2026
Dividend Yield
4.92%
N/A
EPS Growth
N/A
1.23
EPS
N/A
N/A
Revenue
N/A
$297,176,000.00
Revenue This Year
N/A
$13.27
Revenue Next Year
N/A
$17.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.61
52 Week Low
$9.79
$3.86
52 Week High
$10.71
$9.42

Technical Indicators

Market Signals
Indicator
MMU
EOLS
Relative Strength Index (RSI) 32.23 46.33
Support Level $9.91 $5.45
Resistance Level $10.47 $6.25
Average True Range (ATR) 0.10 0.35
MACD -0.05 -0.04
Stochastic Oscillator 9.41 38.83

Price Performance

Historical Comparison
MMU
EOLS

About MMU Western Asset Managed Municipals Fund Inc.

Western Asset Managed Municipals Fd Inc is a non-diversified, closed-end management investment company. Its investment objective is to maximize current income exempted from federal income tax as is consistent with the preservation of principal. The fund predominantly invests in long-term investment grade municipal debt securities issued by state and local governments, political subdivisions, agencies, and public authorities (municipal obligations).

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: